255 related articles for article (PubMed ID: 31106482)
1. Whole transcriptome analysis of diabetic nephropathy in the db/db mouse model of type 2 diabetes.
Wen L; Zhang Z; Peng R; Zhang L; Liu H; Peng H; Sun Y
J Cell Biochem; 2019 Oct; 120(10):17520-17533. PubMed ID: 31106482
[TBL] [Abstract][Full Text] [Related]
2. RNA-Seq analysis reveals critical transcriptome changes caused by sodium butyrate in DN mouse models.
Yang H; Zhang Z; Peng R; Zhang L; Liu H; Wang X; Tian Y; Sun Y
Biosci Rep; 2021 Apr; 41(4):. PubMed ID: 33779731
[TBL] [Abstract][Full Text] [Related]
3. Microarray analysis reveals long non‑coding RNA SOX2OT as a novel candidate regulator in diabetic nephropathy.
Zhang X; Shang J; Wang X; Cheng G; Jiang Y; Liu D; Xiao J; Zhao Z
Mol Med Rep; 2018 Dec; 18(6):5058-5068. PubMed ID: 30320339
[TBL] [Abstract][Full Text] [Related]
4. Microarray analysis of long noncoding RNA expression patterns in diabetic nephropathy.
Chen S; Dong C; Qian X; Huang S; Feng Y; Ye X; Miao H; You Q; Lu Y; Ding D
J Diabetes Complications; 2017 Mar; 31(3):569-576. PubMed ID: 28007334
[TBL] [Abstract][Full Text] [Related]
5. The topological key lncRNA H2k2 from the ceRNA network promotes mesangial cell proliferation in diabetic nephropathy
Chen W; Peng R; Sun Y; Liu H; Zhang L; Peng H; Zhang Z
FASEB J; 2019 Oct; 33(10):11492-11506. PubMed ID: 31336052
[TBL] [Abstract][Full Text] [Related]
6. Whole transcriptome mapping reveals the lncRNA regulatory network of TFP5 treatment in diabetic nephropathy.
Luo H; Yang L; Zhang G; Bao X; Ma D; Li B; Cao L; Cao S; Liu S; Bao L; E J; Zheng Y
Genes Genomics; 2024 May; 46(5):621-635. PubMed ID: 38536617
[TBL] [Abstract][Full Text] [Related]
7. Identification of urinary extracellular vesicles differentially expressed RNAs in diabetic nephropathy via whole-transcriptome integrated analysis.
Zhao Z; Yan Q; Fang L; Li G; Liu Y; Li J; Pan S; Zhou S; Duan J; Liu D; Liu Z
Comput Biol Med; 2023 Nov; 166():107480. PubMed ID: 37738894
[TBL] [Abstract][Full Text] [Related]
8. Bioinformatics Analysis of the Mechanisms of Diabetic Nephropathy
Guo M; Dai Y; Jiang L; Gao J
Front Endocrinol (Lausanne); 2022; 13():934022. PubMed ID: 35909518
[TBL] [Abstract][Full Text] [Related]
9. An integrated RNA sequencing and network pharmacology approach reveals the molecular mechanism of dapagliflozin in the treatment of diabetic nephropathy.
Bai Z; Xie T; Liu T; Chen Z; Yu L; Zhang C; Luo J; Chen L; Zhao X; Xiao Y
Front Endocrinol (Lausanne); 2022; 13():967822. PubMed ID: 36213291
[TBL] [Abstract][Full Text] [Related]
10. Altered Expression of Long Noncoding and Messenger RNAs in Diabetic Nephropathy following Treatment with Rosiglitazone.
Zhang L; Zhou Y; Zhou F; Yu X; Liu J; Liu Y; Zhu Y; Wang W; Chen N
Biomed Res Int; 2020; 2020():1360843. PubMed ID: 32025515
[TBL] [Abstract][Full Text] [Related]
11. Expression of long non‑coding RNA and mRNA in the hippocampus of mice with type 2 diabetes.
Ci LY; Liu DS; Yang JQ; Liu YZ; Li CL; Zhang X; Ma CM; Hu RT
Mol Med Rep; 2018 Dec; 18(6):4960-4968. PubMed ID: 30272307
[TBL] [Abstract][Full Text] [Related]
12. Transcriptome expression profiles associated with diabetic nephropathy development.
Jing J; Song L; Zuo D; Li W; Sun Y; Ma X; Ren J
Mol Cell Biochem; 2022 Jul; 477(7):1931-1946. PubMed ID: 35357607
[TBL] [Abstract][Full Text] [Related]
13. Glomerular expression pattern of long non-coding RNAs in the type 2 diabetes mellitus BTBR mouse model.
Reichelt-Wurm S; Wirtz T; Chittka D; Lindenmeyer M; Reichelt RM; Beck S; Politis P; Charonis A; Kretz M; Huber TB; Liu S; Banas B; Banas MC
Sci Rep; 2019 Jul; 9(1):9765. PubMed ID: 31278342
[TBL] [Abstract][Full Text] [Related]
14. RNA-Seq Analysis of ceRNA-Related Networks in the Regulatory Metabolic Pathway of Mice with Diabetic Nephropathy Subjected to Empagliflozin Intervention.
Wu T; Zhang Z; Huang H; Wu X
Arch Esp Urol; 2023 Nov; 76(9):680-689. PubMed ID: 38053423
[TBL] [Abstract][Full Text] [Related]
15. An integrated network pharmacology and transcriptomic method to explore the mechanism of the total Rhizoma Coptidis alkaloids in improving diabetic nephropathy.
Xiao Y; Liu Y; Lai Z; Huang J; Li C; Zhang Y; Gong X; Deng J; Ye X; Li X
J Ethnopharmacol; 2021 Apr; 270():113806. PubMed ID: 33444721
[TBL] [Abstract][Full Text] [Related]
16. Integrated analysis of transcriptome profiling of lncRNAs and mRNAs in livers of type 2 diabetes mellitus.
Lan X; Han J; Wang B; Sun M
Physiol Genomics; 2022 Feb; 54(2):86-97. PubMed ID: 35073196
[TBL] [Abstract][Full Text] [Related]
17. Identification of potential biomarkers and pathways associated with carotid atherosclerotic plaques in type 2 diabetes mellitus: A transcriptomics study.
Yu T; Xu B; Bao M; Gao Y; Zhang Q; Zhang X; Liu R
Front Endocrinol (Lausanne); 2022; 13():981100. PubMed ID: 36187128
[TBL] [Abstract][Full Text] [Related]
18. Genomic expression profiling and bioinformatics analysis on diabetic nephrology with ginsenoside Rg3.
Wang J; Cui C; Fu L; Xiao Z; Xie N; Liu Y; Yu L; Wang H; Luo B
Mol Med Rep; 2016 Aug; 14(2):1162-72. PubMed ID: 27279428
[TBL] [Abstract][Full Text] [Related]
19. Identification of key lncRNAs contributing to diabetic nephropathy by gene co-expression network analysis.
Shang J; Wang S; Jiang Y; Duan Y; Cheng G; Liu D; Xiao J; Zhao Z
Sci Rep; 2019 Mar; 9(1):3328. PubMed ID: 30824724
[TBL] [Abstract][Full Text] [Related]
20. Key Anti-Fibrosis Associated Long Noncoding RNAs Identified in Human Hepatic Stellate Cell via Transcriptome Sequencing Analysis.
Li XQ; Ren ZX; Li K; Huang JJ; Huang ZT; Zhou TR; Cao HY; Zhang FX; Tan B
Int J Mol Sci; 2018 Feb; 19(3):. PubMed ID: 29495545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
